News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acucela Inc. Appoints Former Bristol-Myers Squibb Company (BMY) and F. Hoffmann-La Roche Ltd. (RHHBY) Executive, Jaisim Shah, to the Company’s Board of Directors


8/3/2011 8:06:19 AM

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that it has appointed Mr. Jaisim Shah to the Company’s Board of Directors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES